Free Trial
NYSEARCA:BBC

Virtus LifeSci Biotech Clinical Trials ETF (BBC) Price, Holdings, & News

$21.19 -0.34 (-1.58%)
As of 07/11/2025 04:10 PM Eastern

About Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC)

Key Stats

Today's Range
$21.19
$21.45
50-Day Range
$16.97
$21.59
52-Week Range
$13.42
$31.65
Volume
14,859 shs
Average Volume
26,955 shs
Market Capitalization
$11.65 million
Assets Under Management
$13.83 million
Dividend Yield
1.09%
Net Expense Ratio
0.79%
Aggregate Rating
Moderate Buy

ETF Overview

Virtus LifeSci Biotech Clinical Trials ETF Expenses

TypeBBCHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.79%0.56%0.56%0.51%0.53%
Other Expenses0.00%0.47%0.56%0.59%0.56%
Total Expense0.79%0.75%0.76%0.74%0.73%
Fee Waiver0.00%-0.67%-0.66%-0.71%-0.63%
Net Expense0.79%0.60%0.63%0.58%0.60%
Receive BBC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Virtus LifeSci Biotech Clinical Trials ETF and its competitors with MarketBeat's FREE daily newsletter.

BBC ETF News Headlines

BBC Virtus LifeSci Biotech Clinical Trials ETF
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Tech ETFs on the Rise After Four Weeks in Deep Red
See More Headlines

BBC ETF - Frequently Asked Questions

Virtus LifeSci Biotech Clinical Trials ETF's stock was trading at $23.94 at the beginning of 2025. Since then, BBC shares have decreased by 11.5% and is now trading at $21.19.

Shares of BBC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Virtus LifeSci Biotech Clinical Trials ETF investors own include NVIDIA (NVDA), Broadcom (AVGO), Adobe (ADBE), Arista Networks (ANET), Meta Platforms (META), e.l.f. Beauty (ELF) and GE Aerospace (GE).

Fund Details

Issuer
Virtus
Fund Name
Virtus LifeSci Biotech Clinical Trials ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:BBC
Inception Date
12/16/2014
Fund Manager
Matthew B. Brown, Seth Kadushin
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
LifeSci Biotechnology Clinical Trials Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
119

Fund Statistics

Assets Under Management
$13.83 million
Average Daily Volume
$43.94 thousand
Discount/Premium
-0.08%

Administrator, Advisor and Custodian

Administrator
Virtus ETF Solutions, LLC
Advisor
Virtus ETF Advisers, LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
ETF Distributors LLC
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
10
Put Options
1
Call Options
10
Short Interest
19,600 shs

Miscellaneous

Beta
1.08
Creation Unit
50,000
Creation Fee
$500.00
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Top 10 BBC Holdings

BBC Sector Exposure

BBC Industry Exposure


This page (NYSEARCA:BBC) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners